Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-187156
Filing Date
2026-04-28
Accepted
2026-04-28 16:20:47
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-28

Document Format Files

Seq Description Document Type Size
1 ARS whwk_-_2025_annual_repor.pdf ARS 3130717
  Complete submission text file 0001193125-26-187156.txt   4311163
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38560 | Film No.: 26908172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)